ZymoGenetics Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins for the treatment of human…
The bio-pharmaceutical company Lorus Therapeutics filed a preliminary short form in Canada. The short form covers the provinces of Ontario,…
Cyberonics recently announced their 4th quarter and fiscal year results. The medical technology company has been gaining traction with their…
Diversified environmental services company, Ecosphere Technologies, Inc. announced Friday that the company will participate in remediation efforts related to the…
Anthera Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, recently…
Yesterday, Genta Inc. announced the presentation of pooled results on early endpoints from their randomized Phase 3 trials of Genasense®…
Blyth, Inc. reported net income of $4.5 million, or $0.51 per diluted share, in the first quarter of 2010 ending…
VIVK is on radar now as a possible reversal play. The last two days have formed a bullish harami pattern…
Cellceutix Corp. was pleased to announce this morning its acknowledgement of the many emails, phone calls and letters received regarding…
Cherokee Inc. reported net income of $2.9 million, or $0.33 per diluted share, in the first quarter of 2010. The…